Pacific Biosciences Of California | PACB - Capital Ordinaire





Capital Ordinaire Changement Date
Agilent USD 282.7M 358K 2025-12
Bruker USD 151.94M 225K 2025-12
Danaher USD 707.7M 800K 2026-03
General Electric Aerospace USD 1.04B 5.43M 2026-03
Illumina USD 151.91M 893K 2026-03
Myriad Genetics USD 93.5M 400K 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quidel USD 67.9M 0 2025-12
Revvity USD 111.8M 1.57M 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Standard Biotools USD 386.38M 2.77M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Waters USD 98.17M 89K 2026-03